Johannes Waldschmidt, MD, studied medicine at the University of Freiburg, Germany; the University of Uppsala, Sweden; and the University of Zurich, Switzerland. He was trained as a hematologist-oncologist at Freiburg University Medical Center, where his experimental work has focused on characterizing the bone marrow microenvironment in multiple myeloma. As postdoctoral fellow in the lab of Jens Lohr, MD, PhD, at the Dana-Farber Cancer Institute in Boston, Waldschmidt studied cancer genomics, clonal evolution and the development of drug resistance in multiple myeloma. He is a recipient of the 2019 Young Investigator Award by the International Myeloma Society.